Invention Grant
- Patent Title: PD-L1 binding fibronectin type III domains
-
Application No.: US15840281Application Date: 2017-12-13
-
Publication No.: US10597438B2Publication Date: 2020-03-24
- Inventor: Michael Diem , Rebecca Hawkins , Steven Jacobs , Manuel Sepulveda
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: JANSSEN BIOTECH, INC.
- Current Assignee: JANSSEN BIOTECH, INC.
- Current Assignee Address: US PA Horsham
- Agency: Pepper Hamilton LLP
- Main IPC: C07K14/705
- IPC: C07K14/705 ; C07K14/71 ; C07K14/78 ; A61P35/00 ; C12N15/85 ; C07K16/28 ; A61K38/17
Abstract:
FN3 domains that specifically bind to PD-L1, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.
Public/Granted literature
- US20180162928A1 PD-L1 Binding Fibronectin Type III Domains Public/Granted day:2018-06-14
Information query
